326. 大理石骨病
[臨床試験数:20,薬物数:52(DrugBank:14),標的遺伝子数:16,標的パスウェイ数:78

Searched query = "Osteopetrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02666768
(ClinicalTrials.gov)
February 22, 201623/6/2015ACTIMMUNE in Intermediate OsteopetrosisOpen-label Early Phase 2 Study With a Single Arm of Interferon Gamma-1b Treatment of OsteopetrosisOsteopetrosisDrug: Interferon gamma-1bLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterUniversity of Minnesota;Horizon Pharma Ireland, Ltd., Dublin IrelandCompleted1 YearN/AAll5Phase 2United States
2NCT02584608
(ClinicalTrials.gov)
January 1, 201620/10/2015Use of ACTIMMUNE in Patients With ADO2Phase 2a Study of Interferon Gamma-1b for the Treatment of Autosomal Dominant Type 2 OsteopetrosisAutosomal Dominant Osteopetrosis Type 2Drug: ACTIMMUNEIndiana UniversityHorizon Pharma Ireland, Ltd., Dublin IrelandCompleted3 Years65 YearsAll12Phase 2United States
3NCT00043329
(ClinicalTrials.gov)
January 20027/8/2002Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant OsteopetrosisPost-Marketing Surveillance Study of Actimmune (Interferon Gamma-1b) in Patients With Severe Malignant OsteopetrosisOsteopetrosisDrug: Actimmune RegistryInterMuneNULLCompletedN/AN/ABoth6United States